RUNX1 and RUNX3 protect against YAP-mediated EMT, stem-ness and shorter survival outcomes in breast cancer

Madhura Kulkarni1,2, Tuan Zea Tan1, Nurfarhanah Bte Syed Sulaiman1

  • 1Cancer Science Institute, NUS, Singapore.

Oncotarget
|March 28, 2018
PubMed

Insights

RUNX1 and RUNX3 suppress the oncogenic YAP protein in breast cancer. This interaction inhibits tumor progression and improves patient survival, offering a new prognostic tool for cancer recurrence.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The Hippo pathway effector, Yes-associated protein (YAP), is a key driver in solid tumor progression.
  • Understanding YAP's regulatory mechanisms is crucial for developing targeted breast cancer therapies.

Purpose of the Study:

  • To identify novel regulators of YAP's oncogenic function in breast cancer.
  • To investigate the interplay between YAP, RUNX1, and RUNX3 in breast cancer progression and patient survival.

Main Methods:

  • Investigated the interaction between RUNX proteins and YAP in mammary epithelial cell lines.
  • Analyzed whole-genome expression profiles of breast cancer samples.
  • Correlated YAP, RUNX1, and RUNX3 expression levels with patient survival outcomes and gene signatures (EMT, stemness).

Main Results:

  • RUNX1 and RUNX3 were identified as novel negative regulators of YAP's oncogenic activity.
  • RUNX1/RUNX3 expression abrogated YAP-mediated pro-tumorigenic properties, including migration and stemness.
  • High RUNX1/RUNX3 expression correlated with better patient survival and reduced enrichment of EMT and stemness signatures, even with high YAP levels.

Conclusions:

  • RUNX1 and RUNX3 antagonize YAP's oncogenic function in breast cancer, providing mechanistic insight into oncogene-tumor suppressor interplay.
  • The YAP-RUNX1/RUNX3 interaction represents a potential prognostic tool for predicting breast cancer recurrence.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
774
Survival Curves01:18

Survival Curves

Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
732
Survival Tree01:19

Survival Tree

Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
436
Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
11.0K
Outcomes of Glycolysis01:13

Outcomes of Glycolysis

Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
107.7K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K